Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 16, 2006 - Issue 5
Submit an article Journal homepage
58
Views
2
CrossRef citations to date
0
Altmetric
Patent Evaluation

Glycopyrrolate combinations for the treatment of respiratory diseases

Sofotec GmbH & Co. KG: US20050175548, US20050175549 & US20050175547

A Guerra PhD Student, Instituto de Química Médica, CSIC, Juan de la Cierva, 3. 28006 Madrid, Spain
,
N E Campillo Research Scientist, Instituto de Química Médica, CSIC, Juan de la Cierva, 3. 28006 Madrid, Spain. [email protected]
&
J A Páez Research Scientist, Instituto de Química Médica, CSIC, Juan de la Cierva, 3. 28006 Madrid, Spain. [email protected]
Pages 723-728 | Published online: 25 Apr 2006

Bibliography

  • Global initiative for chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2005 (based on an April 1998 NHLBI/WHO workshop).
  • BARNES PJ, STOCKLEY RA: COPD: current therapeutic interventions and future approaches. Eur. Respir. J. (2005) 25(6):1084-1106.
  • WEDER MM, DONOHUE JF: Role of bronchodilators in chronic obstructive pulmonary disease. Semin. Respir. Crit. Care. Med. (2005) 26:221-234.
  • DONOHUE JF: Therapeutic responses in asthma and COPD. Bronchodilators. Chest (2004) 126(Suppl.2):125S-137S.
  • Global Strategy for Asthma Management and Prevention, NIH Publication No. 02-3659. Issued January 1995 (updated 2002). Management Segment (chapter 7): updated 2005 from the 2004 document.
  • BARNES PJ: The role of anticholinergics in chronic obstructive pulmonary disease. Am. J. Med. (2004) 117(Suppl.12A):24S-32S.
  • KANKAANRANTA H, LAHDENSUO A, MOILANEN E, BARNES PJ: Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Respir. Res. (2004) 5(1):17.
  • KANAZAWA H: Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling. Curr. Opin. Pulm. Med. (2006) 12(1):60-67.
  • SOMAND H, REMINGTON TL: Tiotropium: a bronchodilator for chronic obstructive pulmonary disease. Ann. Pharmacother. (2005) 39:1467-1475.
  • SABERI F, O’DONNELL DE: The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Treat. Respir. Med. (2005) 4:275-281.
  • TASHKIN DP: Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Curr. Opin. Pulm. Med. (2005) 11:121-128.
  • HANSEL TT, NEIGHBOUR H, ERIN EM et al.: Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma. Chest (2005) 128(4):1974-1979.
  • LECKIE MJ, BRYAN SA, HANSEL TT, BARNES PJ: Novel therapy for COPD. Expert Opin. Investig. Drugs (2000) 9(1):3-23.
  • SCHROECKENSTEIN DC, BUSH RK, CHERVINSKY P, BUSSE WW: Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate. J. Allergy Clin. Immunol. (1988) 82(1):115-119.
  • SKORODIN MS: Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies. Arch. Intern. Med. (1993) 153(7):814-828.
  • WALKER FB, KAISER DL, KOWAL MB, SURATT PM: Prolonged effect of inhaled glycopyrrolate in asthma. Chest (1987) 91(1):49-51.
  • CAZZOLA M, MATERA MG, LOTVALL J: Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin. Investig. Drugs (2005) 14(7):775-783.
  • BALOIRA VILLAR A, VILARINO POMBO C: Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease. Arch. Bronconeumol. (2005) 41:130-134.
  • GARCIA RUIZ AJ, LEIVA FERNANDEZ F, MARTOS CRESPO F: Cost-effectiveness analysis of tiotropium compared to ipratropium and salmeterol. Arch. Bronconeumol. (2005) 41:242-248.
  • VAN NOORD JA, AUMANN JL, JANSSENS E et al.: Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur. Respir. J. (2005) 26:214-222.
  • LIPWORTH BJ: Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet (2005) 365(9454):167-175.
  • HOUSLAY MD, SCHAFER P, ZHANG KY: Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov. Today (2005) 10(22):1503-1519.
  • BOSWELL-SMITH V, SPINA D, PAGE CP: Phosphodiesterase inhibitors. Br. J. Pharmacol. (2006) 147(Suppl.1):S252-S257.
  • ODINGO JO: Inhibitors of PDE4: a review of recent patent literature. Expert Opin. Ther. Patents (2005) 15(7):773-787.

Patents

  • BANNISTER RM, MCGLASHAN RICHARDS AJ, GILBERT JC, MORTON DAV & STANIFORTH J: US20030068280 (2003).
  • ARAKIS KTD, UK: 2005107872 (2005).
  • PHARMACIA CORP.: US20050107349 (2005).
  • UNIV. OF ROCHESTER: US20026482837 (2002).
  • SOFOTEC GMBH & CO. KG: US2005175547 (2005).
  • BOERINGER INGELHEIM PHARMA: US2005107420 (2005).
  • SOFOTEC GMBH & CO. KG: US20050222102 (2005).
  • BANNISTER RM, MCGLASHAN RICHARDS AJ, GILBERT JC, MORTON DAV & STANIFORTH J: US20050019271 (2005).

Websites

  • www.who.int/respiratory/copd/en WHO: Chronic obstructive pulmonary diseases (COPD).
  • www.who.int/respiratory/asthma/en WHO: Bronchial asthma.
  • www.novolizer.nl VIATRIS GmbH & Co. KG: Novolizer® is a multi-dose dry powder inhaler (MDPI).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.